INNOVUS PHARMACEUTICALS, INC.
INNOVUS PHARMACEUTICALS, INC. (INNV) is a publicly traded company in the Unknown sector. Across all available filings, 28 corporate insiders have executed 127 transactions totaling $2.2M, demonstrating a bullish sentiment with $1.4M in net insider flow. The most recent transaction on Dec 1, 2025 involved a transaction of 5,054 shares valued at $27.6K.
INNV Insider Activity Summary
Who Is Buying INNV Stock?
No significant insider buying has been recorded for INNV in the recent period.
Who Is Selling INNV Stock?
No significant insider selling has been recorded for INNV in the recent period.
Is INNOVUS PHARMACEUTICALS, INC. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for INNV is bullish with an Insider Alignment Score of 82/100 and a net flow of $1.4M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
INNV Frequently Asked Questions
Understanding INNV Insider Activity
Insider trading at INNOVUS PHARMACEUTICALS, INC. (INNV) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 28 insiders are actively trading INNV stock, having executed 127 transactions in the past 90 days. The most active insider is Nicole Damato (Executive), who has made 24 transactions totaling $706.7K.
Related Tools
Track INNOVUS PHARMACEUTICALS, INC. Insider Activity
Get notified when executives and directors at INNV file new Form 4 transactions